Neurologic complications of bone marrow and stem-cell transplantation in patients with cancer

Current Treatment Options in Neurology

Volumn 9, Issue 4, 2007, Pages 308-314

  Mathew, Rose Marie ^b   Rosenfeld, Myrna R ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CARBOPLATIN; CARMUSTINE; CEFEPIME; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DIAZEPAM; ETIRACETAM; ETOPOSIDE; GABAPENTIN; GANCICLOVIR; HEMOPOIETIC GROWTH FACTOR; IFOSFAMIDE; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLENE BLUE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; TACROLIMUS; THIOTEPA; UNINDEXED DRUG; VALPROIC ACID;

ACUTE GRAFT VERSUS HOST DISEASE; ALERTNESS; AUDITORY HALLUCINATION; AUTOIMMUNE DISEASE; BLOOD CLOTTING DISORDER; BONE MARROW TRANSPLANTATION; BRAIN DISEASE; CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROVASCULAR DISEASE; COMORBIDITY; CONFUSION; DRUG DOSE REDUCTION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG METABOLISM; DRUG WITHDRAWAL; EPILEPTIC STATE; HALLUCINATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LETHARGY; LYMPHOPROLIFERATIVE DISEASE; MENTAL HEALTH; METABOLIC DISORDER; MORBIDITY; MUSCLE RIGIDITY; MYOCLONUS; MYOPATHY; NEUROLOGIC DISEASE; NEUROTOXICITY; OPPORTUNISTIC INFECTION; OPTIC DISK ANOMALY; OTOTOXICITY; PAIN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETINA DISEASE; REVIEW; SEIZURE; SIDE EFFECT; SOMNOLENCE; TREMOR; VASCULAR DISEASE; VISUAL DISORDER; VISUAL HALLUCINATION;

EID: 34447506069     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-007-0016-3     Document Type: Review

References (33)

1. Bleggi-Torres LF, de Medeiros BC, Werner B, et al.: Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. Bone Marrow Transplant 2000, 25:301-307.
2. Snider S, Bashir R, Bierman P: Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin's disease. Neurology 1994, 44:681-684.
3. de Brabander C, Cornelissen J, Smitt PA, et al.: Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors. J Neurol Neurosurg Psychiatry 2000, 68:36-40.
4. Graus F, Saiz A, Sierra J, et al.: Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 1996, 46:1004-1009.
5. Sostak P, Padovan CS, Yousry TA, et al.: Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 2003, 60:842-848.
6. Faraci M, Lanino E, Dini G, et al.: Severe neurologic complications after hematopoietic stem cell transplantation in children. Neurology 2002, 59:1895-1904.
7. Uckan D, Cetin M, Yigitkanli I, et al.: Life-threatening neurological complications after bone marrow transplantation in children. Bone Marrow Transplant 2005, 35:71-76.
8. Burt RK, Fassas A, Snowden J, et al.: Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 2001, 28:1-12.
9. Openshaw H, Stuve O, Antel JP, et al.: Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology 2000, 54:2147-2150.
10. De La Camara R, Tomas JF, Figuera A, et al.: High dose busulfan and seizures. Bone Marrow Transplant 1991, 7:363-364.
11. Pelgrims J, De Vos F, Van den B J, et al.: Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature. Br J Cancer 2000, 82:291-294.
12. Kassim AA, Chinratanalab W, Ferrara JL, Mineishi S: Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: 'what is the best recipe?'. Bone Marrow Transplant 2005, 36:565-574.
13. Lee HJ, Oran B, Saliba RM, et al.: Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy. Bone Marrow Transplant 2006, 38:299-303.
14. Batchelor TT, Taylor LP, Thaler HT, et al.: Steroid myopathy in cancer patients. Neurology 1997, 48:1234-1238.
15. Freise CE, Rowley H, Lake J, et al.: Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. Transplant Proc 1991, 23:3173-3174.
16. Erer B, Polchi P, Lucarelli G, et al.: CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors. Bone Marrow Transplant 1996, 18:157-162.
17. Gaggero R, Haupt R, Paola FM, et al.: Intractable epilepsy secondary to cyclosporine toxicity in children undergoing allogeneic hematopoietic bone marrow transplantation. J Child Neurol 2006, 21:861-866.
18. Hinchey J, Chaves C, Appignani B, et al.: A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996, 334:494-500.
19. Pranzatelli MR, Mott SH, Pavlakis SG, et al.: Clinical spectrum of secondary parkinsonism in childhood: a reversible disorder. Pediatr Neurol 1994, 10:131-140.
20. Balmaceda CM, Walker RW, Castro-Malaspina H, Dalmau J: Reversal of amphotericin-B-related encephalopathy. Neurology 1994, 44:1183-1184.
21. Krouwer HG, Wijdicks EF: Neurologic complications of bone marrow transplantation. Neurol Clin 2003, 21:319-352.
22. Cree BC, Bernardini GL, Hays AP, Lowe G: A fatal case of coxsackievirus B4 meningoencephalitis. Arch Neurol 2003, 60:107-112.
23. Wainwright MS, Martin PL, Morse RP, et al.: Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001, 50:612-619.
24. Spitzer TR: Engraftment syndrome following hematopoietic stem cell transplantation. J Bone Marrow Transplant 2001, 27:893-898.
25. Oyama Y, Cohen B, Traynor A, et al.: Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplant 2002, 29:81-85.
26. Hoyt R, Szer J, Grigg A: Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 2000, 25:1285-1287.
27. Vos PE, de Boer WA, Wurzer JA, van Gijn J: Subdural hematoma after lumbar puncture: two case reports and review of the literature. Clin Neurol Neurosurg 1991, 93:127-132.
28. Pickhardt PJ, Siegel MJ: Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients. Radiology 1999, 213:73-78.
29. Miller WT Jr, Siegel SG, Montone KT: Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population. Crit Rev Diagn Imaging 1997, 38:569-585.
30. Castellano-Sanchez AA, Li S, Qian J, et al.: Primary central nervous system posttransplant lymphoproliferative disorders. Am J Clin Pathol 2004, 121:246-253.
31. Nozzoli C, Bartolozzi B, Guidi S, et al.: Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma 2006, 47:167-169.
32. Sundin M, Le Blanc K, Ringden O, et al.: The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation. Haematologica 2006, 91:1059-1067.
33. Rosenfeld MR, Pruitt A: Neurologic complications of bone marrow, stem cell, and organ transplantation in patients with cancer. Semin Oncol 2006, 33:352-361.